Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Multiple Sclerosis l: Introduction01:19

Multiple Sclerosis l: Introduction

Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...
Parkinson's Disease: Overview01:15

Parkinson's Disease: Overview

Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is to...
Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders01:27

Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders

Schizophrenia is a neurodevelopmental disorder whose origins are rooted in complex genetic components. Despite our burgeoning understanding, the pathophysiology of this disorder remains incompletely deciphered.
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within the...
Autoimmune Disorders01:29

Autoimmune Disorders

Autoimmune diseases are a group of disorders in which the body's immune system mistakenly attacks its own cells, tissues, and organs. This results from an overactive immune response against substances and tissues normally present in the body. Let's delve into the concept and mechanism of autoimmune diseases from an immune system point of view, explore different causes and examples of such diseases, and discuss potential solutions.
Concept and Mechanism of Autoimmune Diseases
The immune system...
T Cell Types and Functions01:24

T Cell Types and Functions

When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Myasthenia Gravis ll: Pathophysiology01:22

Myasthenia Gravis ll: Pathophysiology

The disease process of myasthenia gravis begins at the neuromuscular junction, where antibodies attack key proteins needed for muscle activation. This immune reaction weakens signal transmission, leading to the characteristic muscle fatigue and weakness that define the condition.Immune-Mediated DamageIn most individuals, antibodies target acetylcholine receptors (AChRs) on the postsynaptic membrane of muscle cells. By blocking acetylcholine binding, these antibodies prevent the nerve signal...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Lipoxin A 4 (LXA 4 ) for diabetic retinopathy (DR).

Indian journal of ophthalmology·2026
Same author

Effect of essential fatty acids (EFAs) and their metabolites on the growth suppressive action of anti-cancer drug doxorubicin on neuro- and glioblastoma cells in vitro.

Prostaglandins & other lipid mediators·2026
Same author

Arachidonic Acid and Lipoxin A4 Protect Pancreatic β-Cells and Improve Hyperglycemia Induced by Bleomycin.

Journal of biochemical and molecular toxicology·2026
Same author

Is Sepsis an Essential Fatty Acids Deficiency State?

Indian journal of critical care medicine : peer-reviewed, official publication of Indian Society of Critical Care Medicine·2025
Same author

Why vitamin C and corticosteroids are inadequate and how essential fatty acids (EFAs) can augment recovery from sepsis.

Nutrition (Burbank, Los Angeles County, Calif.)·2025
Same author

Arachidonic Acid Protects Skeletal Muscle Against Hyperglycaemia-Induced Muscle Atrophy by Modulating Myogenesis and Regulating KLF15 Expression in C57Bl/6 Mice.

FASEB journal : official publication of the Federation of American Societies for Experimental Biology·2025
Same journal

Different approaches of strength-to-muscle mass ratio: impact on 24-month outcomes in patients with acute coronary syndrome.

Nutrition (Burbank, Los Angeles County, Calif.)·2026
Same journal

From scriptural reference to scientific evidence a critical review of the nutritional composition and functional food potential of foods described in classical Islamic texts.

Nutrition (Burbank, Los Angeles County, Calif.)·2026
Same journal

Integrating BIA-derived body composition parameters with GLIM criteria for survival prediction in patients with solid tumors.

Nutrition (Burbank, Los Angeles County, Calif.)·2026
Same journal

Polyunsaturated fatty acids in the prevention, treatment, and survival of breast cancer.

Nutrition (Burbank, Los Angeles County, Calif.)·2026
Same journal

Unpacking the eating pathways: The mediating roles of emotional eating and problem-solving skills in the relationship between childhood trauma and eating expectancies.

Nutrition (Burbank, Los Angeles County, Calif.)·2026
Same journal

Improving communication about dietary fats: development and validation of the Fats-Related Attitude Scale based on data from Brazil, China, Croatia, Poland, and Spain.

Nutrition (Burbank, Los Angeles County, Calif.)·2026
See all related articles

Related Experiment Video

Updated: May 23, 2026

Comprehensive Autopsy Program for Individuals with Multiple Sclerosis
09:41

Comprehensive Autopsy Program for Individuals with Multiple Sclerosis

Published on: July 19, 2019

Is multiple sclerosis a proresolution deficiency disorder?

Undurti N Das1

  • 1UND Life Sciences, Shaker Heights, Ohio, USA. Undurti@hotmail.com

Nutrition (Burbank, Los Angeles County, Calif.)
|April 24, 2012
PubMed
Summary
This summary is machine-generated.

Multiple sclerosis involves excess inflammation due to cytokine imbalance and reduced protective molecules. Enhancing lipoxins, resolvins, and protectins may offer new treatments for this autoimmune disease.

More Related Videos

Quantification of Autoreactive Antibodies in Mice upon Experimental Autoimmune Encephalomyelitis
05:55

Quantification of Autoreactive Antibodies in Mice upon Experimental Autoimmune Encephalomyelitis

Published on: December 1, 2023

Related Experiment Videos

Last Updated: May 23, 2026

Comprehensive Autopsy Program for Individuals with Multiple Sclerosis
09:41

Comprehensive Autopsy Program for Individuals with Multiple Sclerosis

Published on: July 19, 2019

Quantification of Autoreactive Antibodies in Mice upon Experimental Autoimmune Encephalomyelitis
05:55

Quantification of Autoreactive Antibodies in Mice upon Experimental Autoimmune Encephalomyelitis

Published on: December 1, 2023

Area of Science:

  • Neuroimmunology
  • Inflammation Biology

Background:

  • Multiple sclerosis (MS) pathogenesis involves an imbalance of pro-inflammatory and anti-inflammatory cytokines.
  • This imbalance leads to increased reactive oxygen species (ROS), causing neuronal damage.
  • A deficiency in inflammation-resolving mediators contributes to persistent inflammation and delayed repair in MS.

Purpose of the Study:

  • To investigate the role of cytokine imbalance and resolution-inducing molecules in multiple sclerosis.
  • To explore the potential of lipoxins, resolvins, and protectins as therapeutic targets for MS.

Main Methods:

  • Analysis of cytokine profiles in multiple sclerosis.
  • Assessment of reactive oxygen species production.
  • Evaluation of resolution-inducing molecules' function in inflammation and repair.

Main Results:

  • Excessive production of pro-inflammatory cytokines (e.g., IL-1, IL-6, TNF-α) and reduced anti-inflammatory cytokines (e.g., IL-10, IL-4) were observed.
  • Failure to produce adequate resolution-inducing molecules (lipoxins, resolvins, protectins) was identified.
  • These molecular failures contribute to sustained inflammation, impaired healing, and ongoing neuronal damage.

Conclusions:

  • Therapeutic strategies aimed at enhancing lipoxins, resolvins, and protectins show promise.
  • These mediators could offer a novel approach for preventing and treating multiple sclerosis.
  • Targeting these resolution pathways may also benefit other autoimmune diseases.